Literature DB >> 12127671

Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado-Joseph disease.

E Muñoz1, M J Rey, M Milà, A Cardozo, T Ribalta, E Tolosa, I Ferrer.   

Abstract

UNLABELLED: The presence of neuronal intranuclear inclusions (NIIs) and neuronal mosaicism has been described in some autosomal dominant spinocerebellar ataxias (SCA), but their implication in neurodegenerative mechanisms still remains unclear.
OBJECTIVE: To investigate the correlation between neuronal loss and NIIs, and the size of CAG triplet expansion in selected areas of the CNS in two SCA3 patients.
MATERIAL AND METHODS: Postmortem neuropathological study was carried out, and the regional distribution of neuronal loss was compared with NIIs. CAG expansion was analysed by PCR amplification in the same regions.
RESULTS: Marked neuronal loss was seen in the anterior horn of the spinal cord, pontine nuclei and motor nuclei of the brain stem. Moderate neurone loss was found in the locus ceruleus, colliculus and substantia nigra. Loss of granule and Purkinje cells was found in the cerebellum, mainly in the vermis. NIIs were present in neurones of the involved nuclei of the anterior horn of the spinal cord, medulla oblongata and pons, but not in the locus ceruleus, substantia nigra and cerebellum. A few NIIs were found in the striatum. The number of CAG repeats was 27/70 in the first patient and 21/74 in the second patient. The variation of the expanded allele size among different cerebral areas was +/-1-3 CAG repeats.
CONCLUSION: The partial correlation between neuronal loss and NIIs suggests that other factors distinct from NII formation may be involved in the neuronal death. Moreover, the low degree of mosaicism between regions without neuronal loss and regions with marked neuronal loss points to the existence of selective cellular vulnerability to the genetic defect.

Entities:  

Mesh:

Year:  2002        PMID: 12127671     DOI: 10.1016/s0022-510x(02)00110-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

2.  Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).

Authors:  W Scherzed; E R Brunt; H Heinsen; R A de Vos; K Seidel; K Bürk; L Schöls; G Auburger; D Del Turco; T Deller; H W Korf; W F den Dunnen; U Rüb
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

Review 3.  Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Veronica F Colomer Gould
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3.

Authors:  Vikram G Shakkottai; Maria do Carmo Costa; James M Dell'Orco; Ananthakrishnan Sankaranarayanan; Heike Wulff; Henry L Paulson
Journal:  J Neurosci       Date:  2011-09-07       Impact factor: 6.167

5.  Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry.

Authors:  Maria Pikkarainen; Päivi Hartikainen; Hilkka Soininen; Irina Alafuzoff
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

Review 6.  Repeat-associated non-AUG (RAN) translation: insights from pathology.

Authors:  Monica Banez-Coronel; Laura P W Ranum
Journal:  Lab Invest       Date:  2019-03-27       Impact factor: 5.662

7.  Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.

Authors:  Clévio Nóbrega; Isabel Nascimento-Ferreira; Isabel Onofre; David Albuquerque; Mariana Conceição; Nicole Déglon; Luís Pereira de Almeida
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

8.  Spinal cord atrophy in spinocerebellar ataxia type 3 and 6 : impact on clinical disability.

Authors:  Carsten Lukas; Horst K Hahn; Barbara Bellenberg; Kerstin Hellwig; Christoph Globas; Sebastian K Schimrigk; Odo Köster; Ludger Schöls
Journal:  J Neurol       Date:  2008-06-05       Impact factor: 4.849

9.  Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.

Authors:  Clévio Nóbrega; Isabel Nascimento-Ferreira; Isabel Onofre; David Albuquerque; Hirokazu Hirai; Nicole Déglon; Luís Pereira de Almeida
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

10.  PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study.

Authors:  Kathrin Gonsior; Gabriele Anna Kaucher; Patrik Pelz; Dorothea Schumann; Melanie Gansel; Sandra Kuhs; Thomas Klockgether; Sylvie Forlani; Alexandra Durr; Stefan Hauser; Tim W Rattay; Matthis Synofzik; Holger Hengel; Ludger Schöls; Olaf H Rieß; Jeannette Hübener-Schmid
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.